<p>Structures and IC<sub>50</sub> values of the studied ligands 1a, 1b and 2.</p
Structures of chemotypes 1a and 2a and their respective deuterated forms examined in this study.</p
<p>Structures, names and EC<sub>50</sub> of active compounds found in the screen.</p
<p>Chemical structures and ZINC codes of the 10 compounds suggested to be PPARγ partial agonists and...
<p>Chemical structures and IC50 values of the training and test set molecules.</p
<p>Chemical structures of the ionic ligands (DBM and TTA) and of the non-ionic ligands (TPPO, DBSO a...
<p>Chemical structures of the five lead compounds selected for <i>in vivo</i> studies.</p
<p>A) General structure of compounds 1–17 B) General structure of compounds 18–30 C) Structure of co...
<p>Chemical structures of the docked compounds (A) Ligand_7 (B) Ligand_5 (C) ATP (D) Folic acid.</p
<p>Structure of the ligand L-700,417 (<i>N,N-bis(2-hydroxy-1-indanyl)-2,6-diphenylmethyl-4- hydroxy-...
<p>The structures of BC8-15 and two structurally-related derivatives are shown. The IC<sub>50</sub> ...
<p>The chemical structures for the planar TMPyP4 and non-planar TMPyP3, and TMPyP2 porphyrin ligands...
<p>(1) Hydrazine, (2) Putrescine, (3) Hexmethylenediamine, (4) Agmatine, (5) Spermidine, (6) Spermin...
<p>List of Solved Crystal Structures of Human Chymase Co-Crystallized with Different Ligands.</p
<p>The 2D chemical structures of human chymase inhibitors used in this study along with their IC<sub...
<p>Chemical structures of iridium(III) solvato complexes 1–3 bearing different C<sup>∧</sup>N ligand...
Structures of chemotypes 1a and 2a and their respective deuterated forms examined in this study.</p
<p>Structures, names and EC<sub>50</sub> of active compounds found in the screen.</p
<p>Chemical structures and ZINC codes of the 10 compounds suggested to be PPARγ partial agonists and...
<p>Chemical structures and IC50 values of the training and test set molecules.</p
<p>Chemical structures of the ionic ligands (DBM and TTA) and of the non-ionic ligands (TPPO, DBSO a...
<p>Chemical structures of the five lead compounds selected for <i>in vivo</i> studies.</p
<p>A) General structure of compounds 1–17 B) General structure of compounds 18–30 C) Structure of co...
<p>Chemical structures of the docked compounds (A) Ligand_7 (B) Ligand_5 (C) ATP (D) Folic acid.</p
<p>Structure of the ligand L-700,417 (<i>N,N-bis(2-hydroxy-1-indanyl)-2,6-diphenylmethyl-4- hydroxy-...
<p>The structures of BC8-15 and two structurally-related derivatives are shown. The IC<sub>50</sub> ...
<p>The chemical structures for the planar TMPyP4 and non-planar TMPyP3, and TMPyP2 porphyrin ligands...
<p>(1) Hydrazine, (2) Putrescine, (3) Hexmethylenediamine, (4) Agmatine, (5) Spermidine, (6) Spermin...
<p>List of Solved Crystal Structures of Human Chymase Co-Crystallized with Different Ligands.</p
<p>The 2D chemical structures of human chymase inhibitors used in this study along with their IC<sub...
<p>Chemical structures of iridium(III) solvato complexes 1–3 bearing different C<sup>∧</sup>N ligand...
Structures of chemotypes 1a and 2a and their respective deuterated forms examined in this study.</p
<p>Structures, names and EC<sub>50</sub> of active compounds found in the screen.</p
<p>Chemical structures and ZINC codes of the 10 compounds suggested to be PPARγ partial agonists and...
DOI
Add to ORKG